VIRX

Viracta Therapeutics, Inc. Common Stock

Delisted

VIRX was delisted on the 3rd of February, 2025.

67 hedge funds and large institutions have $124M invested in Viracta Therapeutics, Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 19 increasing their positions, 15 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
67
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$497K
Puts
$673K
Net Calls
Net Calls Change

Top Buyers

1 +$8.57M
2 +$5.85M
3 +$4.52M
4
Blackstone Inc
Blackstone Inc
New York
+$1.91M
5
State Street
State Street
Massachusetts
+$749K

Top Sellers

1 -$4.49M
2 -$2.1M
3 -$762K
4
Goldman Sachs
Goldman Sachs
New York
-$724K
5
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$511K
Name Holding Trade Value Shares
Change
Change in
Stake
26
$416K
27
$401K
28
$401K
29
$350K
30
$305K
31
$297K
32
$291K
33
$289K
34
$266K
35
$253K
36
$177K
37
$175K
38
$171K
39
$167K
40
$164K
41
$159K
42
$157K
43
$150K
44
$115K
45
$112K
46
$94K
47
$89K
48
$83K
49
$81K
50
$67K